Sub-Total: $0.00
Nurse
Showing 33–47 of 47 results
-
Individualized Treatment Options for Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists on Glycemic Control, Weight Reduction and Cardiovascular Risk
Read more -
Integrating FcRn and Complement System Therapies for Generalized Myasthenia Gravis
Read more -
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Read more -
New Horizons in Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes with SGLT-2, GLP-1 RAs and DPP-4 Based Therapies
Read more -
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more -
New Paradigms in the Clinical Practice of Inflammatory Bowel Diseases
Read more -
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more -
New Paradigms in the Prevention and Treatment of Migraine with HT1F Agonist and mAb Against CGRP Pathway or its Receptor
Read more -
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more -
Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Read more -
Novel Treatment and Management Options for Chronic Idiopathic Constipation
Read more -
Update on GLP-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus
Read more -
Update on Novel Antiepileptic Drugs in Treatment of Epilepsy
Read more -
Advances in the Diagnosis and Steroid-sparing Treatment with FcRn Inhibitors for Ocular Myasthenia Gravis
Read more -
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more
